2008 Annual Meeting | Menopausal/Andropausal Neurology

Date Tuesday 04/15/08

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Andrew G. Herzog, MD, MSc, FAAN

Topic(s) General Neurology/Neurology of Systemic Disease, Women's Issues

Learning Objectives Participants should be familiar with the reproductive hormonal underpinnings of changes that occur in the development and natural history of neurologic disorders as a result of menopause and andropause as well as the risks and benefits of reproductive hormonal replacement treatment.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
02:15 PM - 02:55 PM		Overview; Epilepsy Andrew G. Herzog, MD, MSc, FAAN
02:55 PM - 03:25 PM		Dementia Victor W. Henderson, MD, FAAN
03:25 PM - 03:45 PM		Discussion
03:45 PM - 04:00 PM		Break
04:00 PM - 04:30 PM		Stroke Cathy A. Sila, MD, FAAN
04:30 PM - 05:00 PM		Migraine Robert Cowan, MD, FAAN
05:00 PM - 05:30 PM		Sleep Disorders Christian Guilleminault, MD
05:30 PM - 06:00 PM		Discussion

Faculty Disclosures
Andrew G. Herzog, MD, MSc, FAAN	Dr. Herzog has nothing to disclose.
Cathy A. Sila, MD, FAAN	Dr. Sila has nothing to disclose.
Victor W. Henderson, MD, FAAN	Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities.
Robert Cowan, MD, FAAN	Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Christian Guilleminault, MD	No disclosure on file

��ɫ��

��ɫ��